ALNYLAM PHARMACEUTICALS INC stock forecast: down to 178.10 USD ALNY stock price prognosis


Forecast for Fri 24 Nov 2023 price 177.53

ALNYLAM PHARMACEUTICALS INC stock price forecast for further price development down to -12.18% (time horizon: 1 day) and price target of 178.10 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ALNYLAM PHARMACEUTICALS INC share price prediction for 2023-11-24 with daily closed price projections

Key Facts

Symbol ALNY 

ISIN US02043Q1076 

CUSIP 02043Q107

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.60)

News <--> Close correlation for next day influence (0.04)

Finance numbers

Revenue 570,943,000.0

Earnings per share -7.55

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

During 2020, we also advanced approaches for lung delivery of siRNAs. Concomitant use of on-label commercially available tafamidis is not prohibited. Additional secondary and exploratory endpoints will be evaluated at 18 months. In December 2020, we completed enrollment in this study. Almost one-third of the world's population have previous or current HBV infection. These provide additional opportunities for third parties to challenge our patents. The cost of preparing and submitting an NDA is substantial. Under the PDUFA, as amended, each NDA must be accompanied by an application fee. The FDA adjusts the PDUFA user fees on an annual basis. We intend to request Fast Track designation for our product candidates, if applicable. It is unclear whether the ACA will be overturned, repealed, replaced, or further amended. We cannot predict what affect further changes to the ACA would have on our business. We do not expect the cost of complying with these laws and regulations to be material. This patient focus has continued as we have transitioned into commercialization. We also continue to advance our growing pipeline of RNAi therapeutic opportunities. There are a limited number of manufacturers that supply synthetic siRNAs. In particular, in March 2010, the ACA, was signed into law. In particular, it is unclear how data transfers to and from the UK will be regulated. Third parties may sue us for infringing their patent rights. Risks Related to CompetitionThe pharmaceutical market is intensely competitive. For example, we developed ONPATTRO for the treatment of hATTR amyloidosis.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 44.53/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.
    • Stock price is under book price value.
    • Price target is under the actual stock price

Institutional ownership list is based on filling form information

Holding name Date Amount
A - BARCLAYS PLC 2023-06-30 210145
EFG Asset Management 2023-06-30 15735
AIA Group Ltd 2023-06-30 12594
China Universal Asset Management Co., Ltd. 2023-06-30 13072
Front Row Advisors LLC 2023-03-31 14

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Delaware Group Equity Funds IV 2023-06-30 41000 Long
Delaware Group Equity Funds IV 2023-06-30 288 Long
MML SERIES INVESTMENT FUND 2023-06-30 13300 Long
Franklin Templeton ETF Trust 2023-06-30 28 Long
Franklin Templeton ETF Trust 2023-06-30 2490 Long


CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1849458 Tanguler Tolga 2023-02-03 SALE Accept Accept Accept Accept
1381994 Ausiello Dennis A 2022-11-21 SALE Reject Reject Reject Accept

Bollinger Bollinger Bands for ALNYLAM PHARMACEUTICALS INC can provide the information where the market is moving based on price information.

ALNYLAM PHARMACEUTICALS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns ALNYLAM PHARMACEUTICALS INC.

On-Balance Volume information for ALNYLAM PHARMACEUTICALS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for ALNYLAM PHARMACEUTICALS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for ALNYLAM PHARMACEUTICALS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for ALNYLAM PHARMACEUTICALS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for ALNYLAM PHARMACEUTICALS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for ALNYLAM PHARMACEUTICALS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for ALNYLAM PHARMACEUTICALS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-10-19 178.10 2023-09-30 12:29
2023-10-20 178.38 2023-09-30 12:29
2023-11-02 177.81 2023-09-30 12:29
2023-11-08 177.69 2023-09-30 12:29
2023-10-18 178.70 2023-09-30 12:29
2023-11-13 177.68 2023-09-30 12:29
2023-11-14 177.61 2023-09-30 12:29
2023-11-03 177.79 2023-09-30 12:29
2023-10-10 178.28 2023-09-30 12:29
2023-10-27 178.16 2023-09-30 12:29
2023-11-10 177.69 2023-09-30 12:29
2023-10-11 178.45 2023-09-30 12:29
2023-10-12 178.60 2023-09-30 12:29
2023-10-23 178.34 2023-09-30 12:29
2023-10-24 177.91 2023-09-30 12:29
2023-10-16 178.74 2023-09-30 12:29
2023-11-15 177.64 2023-09-30 12:29
2023-10-25 177.97 2023-09-30 12:29
2023-11-09 177.65 2023-09-30 12:29
2023-10-17 178.87 2023-09-30 12:29
2023-11-06 177.74 2023-09-30 12:29
2023-11-07 177.71 2023-09-30 12:29
2023-10-30 178.24 2023-09-30 12:29
2023-10-31 177.99 2023-09-30 12:29
2023-11-01 177.80 2023-09-30 12:29
2023-11-16 177.66 2023-09-30 12:29
2023-10-13 178.64 2023-09-30 12:29
2023-10-26 178.04 2023-09-30 12:29
2023-11-17 177.61 2023-09-30 12:29
2023-10-03 177.01 2023-09-30 12:29
2023-10-04 176.30 2023-09-30 12:29
2023-10-05 174.98 2023-09-30 12:29
2023-10-06 175.97 2023-09-30 12:29
2023-10-09 177.95 2023-09-30 12:29
2023-11-20 177.58 2023-09-30 12:29
2023-11-21 177.54 2023-09-30 12:29
2023-11-22 177.52 2023-09-30 12:29
2023-11-23 177.54 2023-09-30 12:29
2023-11-24 177.53 2023-09-30 12:29
Table bellow show Bot decisions related with product
Decision Date Chart Link/Company Name Bot Decision Money # Portfolio Value
2021-08-27 Alnylam Pharmaceuticals Inc buy 154.35 2 562.21
2021-08-30 Alnylam Pharmaceuticals Inc hold 154.35 2 561.37
2021-08-31 Alnylam Pharmaceuticals Inc hold 154.35 2 557.21
2021-09-01 Alnylam Pharmaceuticals Inc hold 154.35 2 548.43
2021-09-02 Alnylam Pharmaceuticals Inc hold 154.35 2 554.71
2021-09-03 Alnylam Pharmaceuticals Inc hold 154.35 2 549.27
2021-09-07 Alnylam Pharmaceuticals Inc hold 154.35 2 530.89
2021-09-08 Alnylam Pharmaceuticals Inc sell 516.97 0 516.97

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.